Apr 1, 2025 · From ideation to implementation, we align public and private organizations around a common cause to achieve breakthrough results. Our goal is to help all people to live longer, healthier lives.

The Foundation for the National Institutes of Health (FNIH) creates and leads alliances and public-private partnerships that advance breakthrough biomedical discoveries and improve the quality of people’s lives. Established by Congress in 1990, the FNIH is a not-for-profit 501(c)(3) charitable organization that convenes public and private partnerships between the NIH, academia, life …

Dr. Stacey Adam is a Vice President at the FNIH, leading many public-private partnerships, such as Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV); the Biomarkers Consortium (Cancer and Metabolic Disorders Steering Committees) and their projects; Accelerating Medicines Partnerships (AMPs)-Common Metabolic Diseases, Heart Failure, and …

Our Programs. We seek to solve complex health challenges and accelerate medical breakthroughs for patients, regardless of who they are, where they live or what disease they have.

Our mission is to create and lead cross-sector efforts that validate and qualify biomarkers and other drug development tools to accelerate better decision making for the development of new therapeutics and health technologies.

EQUAL EMPLOYMENT OPPORTUNITY. It is the intent of the Foundation for the National Institutes of Health (FNIH) to afford equal employment opportunity for all qualified persons regardless of race, color, religion, ancestry, age, sex, national origin, marital status, veteran’s status, disability, sexual orientation, gender identity, family responsibilities, genetic status, or …

Office of the President Julie Louise Gerberding, MD, MPH President and Chief Executive Officer (301) 443-1811 Jane Krmpotich Chief of Staff (301) 443-1811 Growth & Innovation David Carmel, MBA Senior Vice President, Chief Growth and Innovation Officer (301) 402-5311 Communications Geralyn LaNeve Associate Vice President, Communications (301) 435-8819 Suzanne …

One example of a current research project is the Accelerating Medicines Partnership Type 2 Diabetes (AMP T2D) initiative, which enables researchers everywhere to search and analyze genetic and clinical information of individuals with type 2 diabetes through a public portal.This open-source platform is intended to generate new understanding of the disease.

RECOVER-TLC Background. RECOVER-TLC will build on the work of the RECOVER program, which is led by three NIH Institutes: The National Heart, Lung, and Blood Institute (NHLBI); NIAID; and the National Institute of Neurological Disorders and Stroke (NINDS).

Here is the breakdown on the types of therapy ideas we have been receiving. Drugs were the most common category put forward for review (72%), followed by nutrition and diet (11%), manual and physical therapies (8%), complementary and integrative health (4%), devices (4%) and other therapeutics (1%).